- Home
- BTBT vs ATYR Comparison
BTBT vs ATYR Comparison
Compare BTBT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBT
- ATYR
- Stock Information
- Founded
- BTBT 2015
- ATYR 2005
- Country
- BTBT United States
- ATYR United States
- Employees
- BTBT 54
- ATYR N/A
- Industry
- BTBT Finance: Consumer Services
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTBT Finance
- ATYR Health Care
- Exchange
- BTBT Nasdaq
- ATYR Nasdaq
- Market Cap
- BTBT 1.1B
- ATYR 451.3M
- IPO Year
- BTBT 2018
- ATYR 2015
- Fundamental
- Price
- BTBT $3.84
- ATYR $6.04
- Analyst Decision
- BTBT Strong Buy
- ATYR Strong Buy
- Analyst Count
- BTBT 3
- ATYR 6
- Target Price
- BTBT $6.33
- ATYR $20.20
- AVG Volume (30 Days)
- BTBT 64.2M
- ATYR 4.1M
- Earning Date
- BTBT 08-18-2025
- ATYR 08-12-2025
- Dividend Yield
- BTBT N/A
- ATYR N/A
- EPS Growth
- BTBT N/A
- ATYR N/A
- EPS
- BTBT N/A
- ATYR N/A
- Revenue
- BTBT $102,037,923.00
- ATYR N/A
- Revenue This Year
- BTBT $20.87
- ATYR $551.06
- Revenue Next Year
- BTBT $38.28
- ATYR $1,874.58
- P/E Ratio
- BTBT N/A
- ATYR N/A
- Revenue Growth
- BTBT 52.44
- ATYR N/A
- 52 Week Low
- BTBT $1.69
- ATYR $1.58
- 52 Week High
- BTBT $5.74
- ATYR $6.44
- Technical
- Relative Strength Index (RSI)
- BTBT 67.65
- ATYR 71.78
- Support Level
- BTBT $3.12
- ATYR $5.19
- Resistance Level
- BTBT $3.74
- ATYR $5.93
- Average True Range (ATR)
- BTBT 0.41
- ATYR 0.37
- MACD
- BTBT 0.09
- ATYR 0.05
- Stochastic Oscillator
- BTBT 74.00
- ATYR 93.64
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.